ALPS Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $356K | Sell |
54,708
-18,635
| -25% | -$121K | ﹤0.01% | 857 |
|
|
2025
Q1 | $582K | Sell |
73,343
-8,206
| -10% | -$65.1K | ﹤0.01% | 572 |
|
|
2024
Q4 | $1.03M | Buy |
81,549
+12,240
| +18% | +$155K | 0.01% | 473 |
|
|
2024
Q3 | $965K | Buy |
69,309
+1,139
| +2% | +$15.9K | 0.01% | 496 |
|
|
2024
Q2 | $939K | Buy |
68,170
+6,539
| +11% | +$90.1K | 0.01% | 479 |
|
|
2024
Q1 | $1.02M | Buy |
61,631
+1,936
| +3% | +$32K | 0.01% | 482 |
|
|
2023
Q4 | $872K | Sell |
59,695
-4,458
| -7% | -$65.1K | 0.01% | 513 |
|
|
2023
Q3 | $787K | Buy |
64,153
+1,592
| +3% | +$19.5K | 0.01% | 523 |
|
|
2023
Q2 | $747K | Buy |
62,561
+14,078
| +29% | +$168K | 0.01% | 545 |
|
|
2023
Q1 | $648K | Sell |
48,483
-1,373
| -3% | -$18.4K | 0.01% | 543 |
|
|
2022
Q4 | $1.07M | Buy |
49,856
+9,712
| +24% | +$209K | 0.01% | 461 |
|
|
2022
Q3 | $804K | Buy |
40,144
+3,414
| +9% | +$68.4K | 0.01% | 509 |
|
|
2022
Q2 | $657K | Sell |
36,730
-26,941
| -42% | -$482K | 0.01% | 536 |
|
|
2022
Q1 | $632K | Sell |
63,671
-7,997
| -11% | -$79.4K | 0.01% | 398 |
|
|
2021
Q4 | $1.21M | Buy |
+71,668
| New | +$1.21M | 0.01% | 336 |
|